Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 10-1999 | 05-1999 | 12-1998 | 05-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,456 | N/A | 1,810 | 1,020 | 1,020 |
| Depreciation Amortization | 1,456 | 1,080 | 1,080 | 1,020 | 1,020 |
| Accounts receivable | -97 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -73 | N/A | N/A | N/A | N/A |
| Other Working Capital | -2,384 | -4,420 | -4,420 | -2,400 | -2,400 |
| Other Operating Activity | 857 | 0 | 0 | 10 | 10 |
| Operating Cash Flow | $-3,697 | $-3,340 | $-1,530 | $-350 | $-350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -990 | -1,560 | -1,560 | -1,210 | -1,210 |
| Net Acquisitions | -393 | 0 | 0 | 0 | 0 |
| Sale Of Investment | 989 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 355 | 980 | 990 | 7,560 | 7,560 |
| Investing Cash Flow | $-39 | $-580 | $-570 | $6,350 | $6,350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 41 | N/A | N/A | N/A | N/A |
| Debt Repayment | -42 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 468 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 291 | 170 | 450 | -220 | -220 |
| Financing Cash Flow | $758 | $170 | $450 | $-220 | $-220 |
| Beginning Cash Position | 5,377 | N/A | 9,180 | 5,160 | 5,160 |
| End Cash Position | 2,399 | N/A | 7,530 | 10,930 | 10,930 |
| Net Cash Flow | $-2,978 | $-3,750 | $-1,640 | $5,770 | $5,770 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,697 | -3,340 | -1,530 | -350 | -350 |
| Capital Expenditure | -990 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,687 | -3,340 | -1,530 | -350 | -350 |